FDA approves Transcranial Magnetic Stimulation (TMS) for the treatment of obsessive compulsion disorder (OCD)
Today, the U.S. Food and Drug Administration permitted marketing of the Brainsway Deep Transcranial Magnetic Stimulation System for treatment of obsessive compulsive disorder (OCD).
